Reported 0 shares, down 449,161 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 25903000 |
| 2022-03-31 | 11622000 |
| 2022-06-30 | 2072000 |
| 2022-09-30 | 1737000 |
| 2022-12-31 | 2001217 |
| 2023-03-31 | 2372000 |
| 2023-06-30 | 7541171 |
| 2023-09-30 | 4896585 |
| 2023-12-31 | 6174340 |
| 2024-03-31 | 4241354 |
| 2024-06-30 | 938353 |
| 2024-09-30 | 432342 |
| 2024-12-31 | 696458 |
| 2025-03-31 | 578671 |
| 2025-06-30 | 306463 |
| 2025-09-30 | 322813 |
| 2025-12-31 | 137174 |
| 2026-03-31 | 103261 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -449,161 (-100.0%) | 0 | $0 | 2026-08-07 | |
| Q1 2026 | Reduced | 449,161 | -1 (0.0%) | < 0.01% | $103,261 | 2026-05-13 | |
| Q4 2025 | Unchanged | 449,162 | 0 (0.0%) | < 0.01% | $137,174 | 2026-02-12 | |
| Q3 2025 | Unchanged | 449,162 | 0 (0.0%) | < 0.01% | $322,813 | 2025-11-12 | |
| Q2 2025 | Reduced | 449,162 | -186,041 (-29.3%) | < 0.01% | $306,463 | 2025-08-12 | |
| Q1 2025 | Reduced | 635,203 | -3,749 (-0.6%) | < 0.01% | $578,671 | 2025-05-02 | |
| Q4 2024 | Added | 638,952 | +67,977 (11.9%) | < 0.01% | $696,458 | 2025-02-07 | |
| Q3 2024 | New | 570,975 | +570,975 (0.0%) | < 0.01% | $432,342 | 2024-11-13 | |
| Q2 2024 | Reduced | 756,736 | -1,487,367 (-66.3%) | < 0.01% | $938,353 | 2024-08-13 | |
| Q1 2024 | Reduced | 2,244,103 | -94,662 (-4.0%) | < 0.01% | $4,241,354 | 2024-05-10 | |
| Q4 2023 | Added | 2,338,765 | +209,815 (9.9%) | < 0.01% | $6,174,340 | 2024-02-13 | |
| Q3 2023 | Added | 2,128,950 | +62,876 (3.0%) | < 0.01% | $4,896,585 | 2023-11-13 | |
| Q2 2023 | Added | 2,066,074 | +1,401,648 (211.0%) | < 0.01% | $7,541,171 | 2023-08-11 | |
| Q1 2023 | Reduced | 664,426 | -37,755 (-5.4%) | < 0.01% | $2,372,000 | 2023-05-12 | |
| Q4 2022 | Reduced | 702,181 | -76,527 (-9.8%) | < 0.01% | $2,001,217 | 2023-02-13 | |
| Q3 2022 | Reduced | 778,708 | -53,217 (-6.4%) | < 0.01% | $1,737,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 831,925 | -1,549,342 (-65.1%) | < 0.01% | $2,072,000 | 2022-08-12 | |
| Q1 2022 | Added | 2,381,267 | +90,998 (4.0%) | < 0.01% | $11,622,000 | 2022-05-12 | |
| Q4 2021 | Added | 2,290,269 | +129,811 (6.0%) | < 0.01% | $25,903,000 | 2022-02-10 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
54 managers reported CUE BIOPHARMA INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Added | 100 | +96 | < 0.01% | $55 | 11 qtrs |
| PREVAIL INNOVATIVE WEALTH ADVISORS LLC | Reduced | 0 | -18,987 | 0 | $0 | 5 qtrs |
| Sigma Planning Corp | Reduced | 0 | -38,750 | 0 | $0 | 30 qtrs |
| Barclays PLC | Reduced | 0 | -6,029 | 0 | $0 | 34 qtrs |
| MIRAMONTES CAPITAL LLC | Reduced | 0 | -26,041 | 0 | $0 | 3 qtrs |
| Vanguard Global Advisers LLC | Reduced | 0 | -12,997 | 0 | $0 | 2 qtrs |
| UBS Group AG | Reduced | 0 | -88,350 | 0 | $0 | 34 qtrs |
| STIFEL FINANCIAL CORP | Reduced | 0 | -246,556 | 0 | $0 | 29 qtrs |
| Beacon Pointe Advisors LLC | Reduced | 0 | -10,000 | 0 | $0 | 2 qtrs |
| ADVISORY RESEARCH INC | Reduced | 0 | -257,225 | 0 | $0 | 22 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 07, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.